These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 6983871)

  • 1. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus.
    Jones JV; Cumming RH; Bacon PA; Evers J; Fraser ID; Bothamley J; Tribe CR; Davis P; Hughes GR
    Q J Med; 1979 Oct; 48(192):555-76. PubMed ID: 317156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
    Zielinski C; Müller C; Smolen J
    Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA.
    Jones JV; Robinson MF; Parciany RK; Layfer LF; McLeod B
    Arthritis Rheum; 1981 Sep; 24(9):1113-20. PubMed ID: 6975635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N; Bambauer R; Jost W; Schäfer M
    Monatsschr Kinderheilkd; 1990 Jul; 138(7):395-8. PubMed ID: 2398909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report.
    Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR
    Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis for the treatment of severe lupus nephritis: uncontrolled observations.
    Lewis EJ
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):182-7. PubMed ID: 7102667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Two cases of lupus nephritis having a high titer of anti-(histone-DNA) complex antibody without IgG anti-dsDNA antibody].
    Mizushima N; Kubota T; Nanki T; Koike R; Kohsaka H; Miyasaka N
    Rinsho Byori; 1996 Jun; 44(6):585-9. PubMed ID: 8752739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasmapheresis therapy in severe lupus erythematosus D.N.A. serum antodies and erythrocyte sedimentation rate for therapy control (author's transl)].
    Meffert H; Böhm F; Apostoloff E; Kramm HJ
    Dermatol Monatsschr; 1980 May; 166(5):331-5. PubMed ID: 6968281
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
    Liu LL; Li XL; Wang LN; Yao L; Fan QL; Li ZL
    J Clin Apher; 2011; 26(4):174-80. PubMed ID: 21462239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopheresis in the treatment of systemic lupus erythematosus.
    Stewart DW; Ballard JO; Schoolwerth AC
    Trans Am Soc Artif Intern Organs; 1984; 30():222-6. PubMed ID: 6335931
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis in five dogs with systemic immune-mediated disease.
    Matus RE; Gordon BR; Leifer CE; Saal S; Hurvitz AI
    J Am Vet Med Assoc; 1985 Sep; 187(6):595-9. PubMed ID: 4086366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial plasmapheresis treatment results in glomerulonephritis].
    Nenov D; Stanchev I; Chankova P
    Vutr Boles; 1981; 20(2):105-8. PubMed ID: 7257329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe infections in plasmapheresis-treated systemic lupus erythematosus.
    Aringer M; Smolen JS; Graninger WB
    Arthritis Rheum; 1998 Mar; 41(3):414-20. PubMed ID: 9506568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis: an adjunct therapy in severe progressive neuropsychiatric lupus.
    Gokhale YA; Bhide S; Rajadhyaksha S; Bichile LS; Hase NK
    J Assoc Physicians India; 2001 Oct; 49():986-9. PubMed ID: 11848331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.